EGF RECEPTOR IN NEOPLASIA AND METASTASIS

被引:262
作者
KHAZAIE, K [1 ]
SCHIRRMACHER, V [1 ]
LICHTNER, RB [1 ]
机构
[1] SCHERING AG,SERV,W-1000 BERLIN 65,GERMANY
关键词
EGFR; NEOPLASIA; METASTASIS;
D O I
10.1007/BF00665957
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EGFR is a member of the tyrosine kinase family of cell surface receptors with a wide range of expression throughout development and in a variety of different cell types. The receptor can transmit signals to cells: i) upon interaction with ligands such as EGF, TGFalpha, amphiregulin or heparin binding EGF, ii) upon truncation or mutation of extracellular and/or intracellular domains, iii) upon amplification of a basal receptor activity (in the absence of ligand) through cooperation with other cellular signaling pathways or nuclear events (e.g. expression of v-erbA). The activated EG FR can exert pleiotropic functions on cells, depending on their tissue origin and state of differentiation. Under certain conditions it can also contribute to neoplasia and development of metastases. Such conditions can exist upon aberrant receptor/ligand expression and activation (e.g. in the wrong cell; at the wrong time; in the wrong amounts). Aberrant signalling can also occur through constitutive EGFR activation. Oncogenic potential of EGFR has been demonstrated in a wide range of experimental animals. EGFR is also implicated in human cancer, where it may contribute both to the initiation (glioblastoma) and progression (epithelial tumors) of the disease. EGFR may influence key steps in the processes of tumor invasion and dissemination. Involvement of EGFR in tumor spread may indicate a potential use of this receptor as a target for antimetastatic therapy.
引用
收藏
页码:255 / 274
页数:20
相关论文
共 218 条
[111]  
KORCZAK B, 1990, P ANN M AM ASS CAN A, V31, pA438
[112]   SIGNAL TRANSDUCTION BY INTEGRINS - INCREASED PROTEIN TYROSINE PHOSPHORYLATION CAUSED BY CLUSTERING OF BETA-1 INTEGRINS [J].
KORNBERG, LJ ;
EARP, HS ;
TURNER, CE ;
PROCKOP, C ;
JULIANO, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8392-8396
[113]   ALTERATION IN GROWTH, CELL MORPHOLOGY, AND CYTOSKELETAL STRUCTURES OF KB CELLS INDUCED BY EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH FACTOR-BETA [J].
KOYASU, S ;
KADOWAKI, T ;
NISHIDA, E ;
TOBE, K ;
ABE, E ;
KASUGA, M ;
SAKAI, H ;
YAHARA, I .
EXPERIMENTAL CELL RESEARCH, 1988, 176 (01) :107-116
[114]   THE INSULIN-LIKE GROWTH FACTOR-I RECEPTOR IS OVEREXPRESSED IN PSORIATIC EPIDERMIS, BUT IS DIFFERENTIALLY REGULATED FROM THE EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
KRANE, JF ;
GOTTLIEB, AB ;
CARTER, DM ;
KRUEGER, JG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1081-1090
[115]  
KUBOTA S, 1992, J BIOL CHEM, V267, P4285
[116]  
LAIHO M, 1989, CANCER RES, V49, P2533
[117]   CELLULAR ONCOGENES AND MULTISTEP CARCINOGENESIS [J].
LAND, H ;
PARADA, LF ;
WEINBERG, RA .
SCIENCE, 1983, 222 (4625) :771-778
[118]   THE EPIDERMAL GROWTH-FACTOR - A REVIEW OF STRUCTURAL AND FUNCTIONAL-RELATIONSHIPS IN THE NORMAL ORGANISM AND IN CANCER-CELLS [J].
LAURENCE, DJR ;
GUSTERSON, BA .
TUMOR BIOLOGY, 1990, 11 (05) :229-261
[119]  
LEE DC, 1990, HDB EXPT PHARM, P611
[120]   RECIPROCAL EFFECTS OF EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR-BETA ON THE ANCHORAGE-DEPENDENT AND ANCHORAGE-INDEPENDENT GROWTH OF A431 EPIDERMOID CARCINOMA-CELLS [J].
LEE, K ;
TANAKA, M ;
HATANAKA, M ;
KUZE, F .
EXPERIMENTAL CELL RESEARCH, 1987, 173 (01) :156-162